These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Relationship between DST nonsuppression and shortened REM latency in schizophrenia. Tandon R; Lewis C; Taylor SF; Shipley JE; DeQuardo JR; Jibson M; Goldman M Biol Psychiatry; 1996 Oct; 40(7):660-3. PubMed ID: 8886301 [No Abstract] [Full Text] [Related]
4. Negative and depressive symptoms in suicidal schizophrenics. Jones JS; Stein DJ; Stanley B; Guido JR; Winchel R; Stanley M Acta Psychiatr Scand; 1994 Feb; 89(2):81-7. PubMed ID: 8178667 [TBL] [Abstract][Full Text] [Related]
5. Dexamethasone nonsuppression and short rapid eye movement latency in schizophrenia: markers of an affective diathesis? Goldman M; Tandon R; Taylor SF; DeQuardo JR; Shipley JE; Patel B; Reddig S; Jibson M Biol Psychiatry; 1996 Nov; 40(9):927-9. PubMed ID: 8896782 [No Abstract] [Full Text] [Related]
6. The dexamethasone suppression test as a predictor of suicidal behavior in unipolar depression. Yerevanian BI; Feusner JD; Koek RJ; Mintz J J Affect Disord; 2004 Dec; 83(2-3):103-8. PubMed ID: 15555702 [TBL] [Abstract][Full Text] [Related]
7. Dexamethasone suppression test and suicide attempts in schizophrenic patients. Płocka-Lewandowska M; Araszkiewicz A; Rybakowski JK Eur Psychiatry; 2001 Nov; 16(7):428-31. PubMed ID: 11728857 [TBL] [Abstract][Full Text] [Related]
8. The dexamethasone suppression test and negative symptoms of schizophrenia. McGauley GA; Aldridge CR; Fahy TA; Eastment C Acta Psychiatr Scand; 1989 Dec; 80(6):548-53. PubMed ID: 2618777 [TBL] [Abstract][Full Text] [Related]
9. [Influence of depressive history on biological parameters in major depression]. Van Wijnendaele R; Hubain P; Dramaix M; Mendlewicz J; Linkowski P Encephale; 2002; 28(1):51-8. PubMed ID: 11963343 [TBL] [Abstract][Full Text] [Related]
10. Suicidality and Survivability in Schizophrenia. Naguy A; Al-Rabaie A J Nerv Ment Dis; 2017 Jul; 205(7):585. PubMed ID: 28657961 [No Abstract] [Full Text] [Related]
14. Positive and negative symptoms as risk factors for later suicidal activity in schizophrenics versus depressives. Kaplan KJ; Harrow M Suicide Life Threat Behav; 1996; 26(2):105-21. PubMed ID: 8840415 [TBL] [Abstract][Full Text] [Related]
15. Platelet 5-HT levels and hypothalamic-pituitary-adrenal axis activity in schizophrenic patients with positive and negative symptoms. Pivac N; Mück-Seler D; Jakovljević M Neuropsychobiology; 1997; 36(1):19-21. PubMed ID: 9211439 [TBL] [Abstract][Full Text] [Related]
16. The InterSePT suicide scale for prediction of imminent suicidal behaviors. Ayer DW; Jayathilake K; Meltzer HY Psychiatry Res; 2008 Oct; 161(1):87-96. PubMed ID: 18786729 [TBL] [Abstract][Full Text] [Related]
17. Depression, negative and positive symptoms, and the DST in schizophrenia. Minas IH; Jackson HJ; Joshua SD; Burgess PM Schizophr Res; 1990; 3(5-6):321-7. PubMed ID: 2282337 [TBL] [Abstract][Full Text] [Related]
18. Clinical significance of sleep EEG abnormalities in chronic schizophrenia. Yang C; Winkelman JW Schizophr Res; 2006 Feb; 82(2-3):251-60. PubMed ID: 16377158 [TBL] [Abstract][Full Text] [Related]
19. [Suicidal behavior of schizophrenic patients in a psychiatric hospital]. Schmölzer C; Wolfersdorf M; Hole G Schweiz Arch Neurol Psychiatr (1985); 1991; 142(2):155-69. PubMed ID: 1710390 [TBL] [Abstract][Full Text] [Related]
20. Abnormal rapid eye movement latencies in schizophrenia. Zarcone VP; Benson KL; Berger PA Arch Gen Psychiatry; 1987 Jan; 44(1):45-8. PubMed ID: 3800583 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]